Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein linking human coagulation factor VIIa with human albumin

EU orphan designation number: EU/3/11/863   
Active ingredient: Recombinant fusion protein linking human coagulation factor VIIa with human albumin
Indication: Treatment of haemophilia B
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Centralised Orphan - Designation EMA/OD/133/10 (2011)3489 of 13/05/2011